A failure to properly screen thousands of women for cervical cancer is equivalent to their exposure to a toxic material, the Pennsylvania Supreme Court heard Monday during oral arguments in Pittsburgh over the viability of a class action claim for medical monitoring.

In Walter v. Magee-Womens Hospital, the Superior Court affirmed a trial court ruling that the plaintiffs failed to state a claim for medical monitoring based on allegations that the Pittsburgh hospital had used under-qualified technicians to review their Pap smears rather than board certified pathologists.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]